Question · asked by 1 review
Calcium channel blockers vs placebo: Severity of attacks
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Calcium channel blockers vs placebo Severity of attacks Average severity per attack assessed on a 10‐cm visual analogue scale (0 = no symptoms, 10 = maximal severity) · patients with Raynaud's phenomenon Calcium channel blockers for primary and secondary Raynaud's phenomenon (2017) · Cochrane Headline outcomes only | no estimate extracted | 18 studies · 415 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Calcium channel blockers for primary and secondary Raynaud's phenomenon 2017 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.